Under construction – not a live service
Sign in
Taking people in FranceNo phase

Reviewing How Closely Soft Tissue Sarcoma Care Follows Guidelines and Links to Survival

Looks back at whether soft tissue sarcoma care followed guidelines, and survival.

Plain-language title generated from the registry record
Registry title: Sarcoma Care Adherence and Survival in Strasbourg

Key facts

Where
Strasbourg, FranceSee the site

Where in France

  • Service d'hématologie-oncologie pédiatrique - CHU de Strasbourg - FranceStrasbourg, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Strasbourg, France
Trial code
NCT07864870
Record updated
8 October 2026
Original description
This retrospective monocentric study evaluates adherence to international clinical practice guidelines for soft tissue sarcoma management in Strasbourg and its impact on overall survival. It also compares practices and outcomes between two periods (2010-2016 and 2017-2024).Read full original descriptionShow less

Sarcoma Adherence to Good Practice and Effect on Survival: A Retrospective Monocentric Study

This retrospective monocentric study evaluates adherence to international clinical practice guidelines for soft tissue sarcoma management in Strasbourg and its impact on overall survival. It also compares practices and outcomes between two periods (2010-2016 and 2017-2024).

Inclusion: Patient aged 18 years or older at first multidisciplinary tumor board presentation; Presented for multidisciplinary tumor board evaluation for soft tissue or visceral tumor; First presentation between 01/01/2017 and 31/12/2024; Absence of opposition to reuse of medical data for research purposes.

Exclusion: Patient younger than 18 years at first presentation; Presence of opposition to reuse of medical data for research purposes; Bone tumors, gastrointestinal stromal tumors (GIST), or Kaposi sarcoma; First presentation outside the study period; Management outside Alsace-Moselle; Duplicate records.

ClinicalTrials.gov NCT07864870